Patents Assigned to DATES BIO CO., LTD.
  • Mesenchymal stem cells that enable tumor targeting improvement and virus mass-production
    Patent number: 12778998
    Abstract: The present invention relates to the preparation of mesenchymal stem cells, which are for the proliferation of viral vectors and viruses, and enable virus production and release timing control such that tumor targeting can be improved and viruses can be mass-produced. In addition, the tumorigenesis of mesenchymal stem cells of the present invention can be fundamentally blocked, safety is secured by enabling virus production and release to be controlled at desired time points, and antitumor effects can be maximized.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: November 3, 2026
    Assignee: DATES BIO CO., LTD.
    Inventors: Jae Jin Song, Soo Jin Choi, Jeong A Hong, Hye Jin Choi